Detalles de la búsqueda
1.
Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study.
BMC Psychiatry
; 15: 278, 2015 Nov 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-26567159
2.
A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection.
BMC Psychiatry
; 14: 7, 2014 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24423017
3.
Safety and efficacy of olanzapine in the long-term treatment of Japanese patients with bipolar I disorder, depression: an integrated analysis.
Psychiatry Clin Neurosci
; 68(7): 498-505, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24417745
4.
Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study.
BMC Psychiatry
; 13: 138, 2013 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-23672672
5.
Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression.
Br J Psychiatry
; 201(5): 376-82, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22918966
6.
Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia.
BMC Psychiatry
; 11: 28, 2011 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21324135
7.
Early response predicts subsequent response to olanzapine long-acting injection in a randomized, double-blind clinical trial of treatment for schizophrenia.
BMC Psychiatry
; 11: 152, 2011 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-21943257
8.
Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine.
Hum Psychopharmacol
; 26(6): 422-33, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21823172
9.
Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases.
BMC Psychiatry
; 10: 43, 2010 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20537128
10.
Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism.
BMC Psychiatry
; 10: 45, 2010 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20537130
11.
A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation.
Neuropsychiatr Dis Treat
; 11: 1349-57, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26064053
12.
Incidences of extrapyramidal symptoms in patients with schizophrenia after treatment with long-acting injection (depot) or oral formulations of olanzapine.
Clin Schizophr Relat Psychoses
; 7(4): 216-22, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23428782
13.
Long-term safety and efficacy of olanzapine long-acting injection in patients with schizophrenia or schizoaffective disorder: a 6-year, multinational, single-arm, open-label study.
Int Clin Psychopharmacol
; 29(6): 322-31, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24850228
14.
Within-drug benefit-risk evaluation of olanzapine long-acting injection at one and two years of treatment.
Int J Methods Psychiatr Res
; 23(4): 439-50, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24996038
15.
Treatment-completion rates with olanzapine long-acting injection versus risperidone long-acting injection in a 12-month, open-label treatment of schizophrenia: indirect, exploratory comparisons.
Int J Gen Med
; 5: 391-8, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22615534
Resultados
1 -
15
de 15
1
Próxima >
>>